價格 | ¥34600 |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:CD229, Human, 重組蛋白 (His & Avi), Biotinylated | 英文名稱:CD229 Protein, Human, Recombinant (His & Avi), Biotinylated |
品牌: TargetMol | 產(chǎn)地: 美國 |
保存條件: Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. | 產(chǎn)品類別: 抑制劑 |
貨號: TMPK-00358 |
名稱 | CD229 Protein, Human, Recombinant (His & Avi), Biotinylated |
描述 | CD229 was strongly and homogeneously overexpressed on the PC of patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma, MM, and PC leukemia. CD229 was particularly overexpressed on those PC showing an abnormal phenotype such as expression of CD56. Most importantly, CD229 was also highly expressed on those cells in the patients' BM displaying the phenotype of chemotherapy-resistant and myeloma-propagating cells. CD229 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 47.7 kDa and the accession number is Q9HBG7-1. |
存儲條件 | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. |
關(guān)鍵字 | CD-229 | SLAMF-3 | T 100 | AI 893573 | SLAMF 3 | LY 9 | CD 229 | LY-9 | AI-893573 | T-100 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學試劑,生物技術(shù)服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥2360 |
VIP4年
|
上海博爾森生物科技有限公司
|
2024-11-15 | |
¥1950 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2024-11-15 | |
詢價 |
VIP1年
|
北京百普賽斯生物科技股份有限公司
|
2024-11-12 |